GE Boosts Cerapedics' Liquidity - Analyst Blog

By Zacks Equity Research,

Shutterstock photo

GE Capital Healthcare Financial Services, an operating unit of General Electric Company ( GE ), recently acted as the lender for a term loan worth $9 million for privately-held medical device company Cerapedics, Inc. The transaction will likely enhance the liquidity of Cerapedics and facilitate its working capital requirements to fuel further growth.

Colorado-based Cerapedics is a premier orthobiologics company focused on developing and commercializing proprietary synthetic small peptide (P-15) technology platform called i-FACTOR. This technology platform utilizes a small peptide as an attachment factor to stimulate the natural bone healing process and is reportedly the only biologic bone graft available in the world. The mechanism supports safer and more predictable bone formation at a lower cost compared to commercially available bone growth factors.

Cerapedics is currently enrolling patients in a clinical trial in the U.S. to assess the safety and effectiveness of P-15 Bone Putty. This orthobiologics company will utilize a significant portion of its enhanced liquidity to fund the regulatory process.

Serving over 100 million customers worldwide, General Electric is one of the largest and the most diversified technology and financial services corporations in the world, with products and services ranging from aircraft engines, power generation, water processing, and security technology to medical imaging, business and consumer financing, media content and industrial products. Its segments include Power & Water, Oil & Gas, Energy Management, Aviation, Healthcare, Transportation, Home & Business Solutions and GE Capital.

With more than $65 billion debt financing transactions in the last 10 years across 45 healthcare sectors, GE Capital Healthcare Financial Services has an in-depth industry know-how and expertise as a reliable debt provider.

General Electric currently has a Zacks Rank #3 (Hold). Other stocks that look promising and are worth considering now in the industry include Icahn Enterprises, L.P. ( IEP ), Carlisle Companies Inc. ( CSL ) and ITT Corp. ( ITT ). While Icahn carries a Zacks Rank #1 (Strong Buy), both Carlisle and ITT carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CARLISLE COS IN (CSL): Free Stock Analysis Report

GENL ELECTRIC (GE): Free Stock Analysis Report


ITT CORP (ITT): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Business , Stocks
Referenced Stocks: CSL , GE , IEP , ITT

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by